Klebsiella pneumoniae subspecies rhinoscleromatis: Difference between revisions

From IDWiki
Klebsiella pneumoniae subspecies rhinoscleromatis
Content deleted Content added
Created page with "* A chronic granulomatous disease of nasal and respiratory tract caused by ''Is caused by::Klebsiella pneumoniae'' subspecies ''rhinoscleromatis'' * Primarily found in dev..."
 
No edit summary
Line 1: Line 1:
== Background ==

=== Microbiology ===
* A chronic granulomatous disease of nasal and respiratory tract caused by ''[[Is caused by::Klebsiella pneumoniae]]'' subspecies ''rhinoscleromatis''
* A chronic granulomatous disease of nasal and respiratory tract caused by ''[[Is caused by::Klebsiella pneumoniae]]'' subspecies ''rhinoscleromatis''
* Also known as respiratory scleroma
* Primarily found in developing countries worldwide

=== Epidemiology ===
* Primarily found in developing countries worldwide, in particular Mexico, Central America, and the Middle East
* Transmitted by close contact
* Transmitted by close contact

== Clinical Manifestations ==
* Presents with nodules or masses in the nasal passages or other parts of the naso- or oropharynx or respiratory tract
* Presents with nodules or masses in the nasal passages or other parts of the naso- or oropharynx or respiratory tract

== Diagnosis ==
* Biopsy shows granulomatous inflammation with foamy macrophages
* Biopsy shows granulomatous inflammation with foamy macrophages

== Manageemnt ==
* Treated with 6 to 8 weeks of antibiotics, but high relapse rate
* Treated with 6 to 8 weeks of antibiotics, but high relapse rate



Revision as of 16:19, 13 January 2026

Background

Microbiology

  • A chronic granulomatous disease of nasal and respiratory tract caused by Klebsiella pneumoniae subspecies rhinoscleromatis
  • Also known as respiratory scleroma

Epidemiology

  • Primarily found in developing countries worldwide, in particular Mexico, Central America, and the Middle East
  • Transmitted by close contact

Clinical Manifestations

  • Presents with nodules or masses in the nasal passages or other parts of the naso- or oropharynx or respiratory tract

Diagnosis

  • Biopsy shows granulomatous inflammation with foamy macrophages

Manageemnt

  • Treated with 6 to 8 weeks of antibiotics, but high relapse rate